Gilead announces third quarter 2026 results with strong growth
The company reports a 16% year-over-year increase in base business, marking its highest growth rate in over ten years.
Stay informed with the latest news and media coverage for the biggest companies in Pharmaceuticals. We track all announcements, press releases, and industry mentions in real time, all in one place. Looking for another sector? Browse our industry database.
Last updated
The company reports a 16% year-over-year increase in base business, marking its highest growth rate in over ten years.
Börje Ekholm replaces outgoing Chair David Meek at the 2027 AGM, bringing extensive global leadership experience to Sobi.
The company targets a November 2026 PDUFA for D-PLEX100, a 2027 US launch, and a pre-IND meeting for PD01B in late 2027.
Growth occurred across all segments, exceeding expectations. The company continues to strengthen execution and make steady progress in business performance.
Unlock all announcements with a free trial
Gilead Sciences, Inc. announced today its results of operations for the third quarter 2026.. Total...
The biopharmaceutical company said it now expects full-year product sales of $31 billion to $31.3 billion, up from $30.1 billion to $30.4 billion.
Novavax President and Chief Executive Officer John C. Jacobs said the partnership has generated more than $1 billion in revenue for Novavax to date. He...
NEW YORK, Oct. 29, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors...
Unlock all articles with a free trial
Track Every Market Move
Follow your target companies and get daily news updates delivered straight to your inbox
Start free trialBrowse the top companies in Pharmaceuticals and stay on top of their latest developments.